Talk:Main Page: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
<div style="display: inline-block; width:100%;"> | <div style="display: inline-block; width:100%;"> | ||
{{Bubble | {{Bubble | ||
Revision as of 04:46, 24 September 2022
Research Updates
Testosterone levels achieved by medically treated transgender women in a United States endocrinology clinic.
This study assessed the anonymous medical records of 98 trans women taking spironolactone as part of their feminizing regimen, and assessed how much their testosterone levels dropped over time. * Please note that spironolactone is not an anti-gonadotropin and thus does not aim to suppress testosterone production, instead it is an androgen receptor antagonist and instead prevents androgens from activating the receptor. This is a common misconception that can lead to fairly useless data when testing for testosterone levels.
The Papers page is a thorough compendium of up-to-date trans-specific research with a high quality of evidence, as well as guides on ways to access them, or find more research.
It is at the heart of all our goals stated in the "About Us" tab below, and one of the more polished articles on the wiki having been curated by our research librarian LilianaUmbra.
[+] All Pages
[+] Recent Changes